Alzheimer’s disease has long been associated with the buildup of amyloid plaques and tau tangles in the brain. But a groundbreaking new study suggests the story is far more complex — and that the real culprit may lie in the breakdown of communication between brain cells, not just the accumulation of toxic proteins.

Researchers at the Icahn School of Medicine at Mount Sinai have mapped out the intricate protein networks in nearly 200 human brain tissue samples, uncovering a critical role for a protein called AHNAK in driving the disease’s progression. Their findings, published in Cell, could open new doors for therapies that target the root causes of Alzheimer’s, rather than just its symptoms.

Why This Matters for Public Health

Alzheimer’s affects more than 55 million people worldwide, according to the World Health Organization, and cases are expected to nearly triple by 2050. Current treatments offer only modest benefits, and most focus on clearing plaques or tangles. But this new research shifts the focus to the broader ecosystem of brain cells — and how their communication fails in Alzheimer’s.

“Alzheimer’s isn’t just about plaques or dying neurons,” said Dr. Bin Zhang, lead author and professor of neurogenetics at Mount Sinai. “It’s about the deterioration of the entire brain ecosystem. Our study shows that losing healthy communication between neurons and glial cells may be a major driver of disease progression.”

How the Study Was Done

The team used advanced proteomic profiling to measure the activity of over 12,000 proteins in brain tissue from people with and without Alzheimer’s. By applying computational modeling, they mapped out how these proteins interact — and where those interactions break down in the disease.

“We took a broad, unbiased approach,” said Dr. Junmin Peng, co-author and professor at St. Jude Children’s Research Hospital. “Instead of focusing on one or two proteins, we looked at the whole network. This allowed us to see the bigger picture of what’s going wrong in Alzheimer’s.”

The Role of AHNAK and Glial Cells

The most striking finding was the central role of AHNAK, a protein found mainly in astrocytes — a type of glial cell that supports and protects neurons. In Alzheimer’s brains, AHNAK levels rise as the disease progresses, and this increase is linked to higher levels of toxic proteins like beta-amyloid and tau.

When researchers reduced AHNAK in lab-grown human brain cells, they saw a drop in tau levels and improved neuronal function. “These results suggest AHNAK could be a promising therapeutic target,” said Dr. Dongming Cai, co-author and professor at the University of Minnesota. “By lowering its activity, we observed less toxicity and better brain cell function — encouraging signs that we might be able to restore healthier brain activity.”

“Alzheimer’s isn’t just about plaques or dying neurons. It’s about the deterioration of the entire brain ecosystem.”

— Dr. Bin Zhang, Icahn School of Medicine at Mount Sinai

Broader Implications and Future Research

The study also identified more than 300 other proteins that may play a role in Alzheimer’s, many of which have not been studied before. The researchers found that factors like genetics and sex can influence how these protein networks behave — for example, people with the APOE4 gene, a known risk factor for Alzheimer’s, showed different patterns of network disruption.

All the data from the study is publicly available, allowing scientists around the world to build on these findings and accelerate progress toward new treatments.

• Alzheimer’s affects over 55 million people globally (WHO).
• Current treatments offer only modest benefits.
• New research highlights the importance of brain cell communication, not just protein buildup.
• AHNAK is a promising new therapeutic target.
• Data is publicly available for further research.

Why This Story Matters

This research could lead to more effective treatments for Alzheimer’s by targeting the underlying causes of brain cell breakdown, not just the symptoms. It also underscores the importance of understanding the complex networks that keep our brains healthy — and how they fail in disease.

“This study opens a new perspective on Alzheimer’s,” said Dr. Zhang. “By understanding these communications and their failures, we can start to develop treatments that restore balance to the system.”

For more on the latest in Alzheimer’s research, follow us on Twitter and Instagram.

*The information in this article is based on peer-reviewed research and expert analysis. For personal health concerns, please consult a qualified healthcare professional.